The electroencephalographic sleep pattern in schizophrenic patients treated with clozapine or classical antipsychotic drugs

Journal of Psychiatric Research

Volumn 30, Issue 6, 1996, Pages 411-419

  Wetter, Thomas C ^a   Lauer, Christoph J ^a   Gillich, Gerlinde ^a   Pollmächer, Thomas ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; FLUPENTIXOL; HALOPERIDOL; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; REM SLEEP; SCHIZOPHRENIA; SLEEP PATTERN;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; CROSS-SECTIONAL STUDIES; ELECTROENCEPHALOGRAPHY; FEMALE; FLUPENTHIXOL; HALOPERIDOL; HUMANS; MALE; POLYSOMNOGRAPHY; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SLEEP STAGES; SLEEP, REM;

EID: 0030293802     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(96)00022-2     Document Type: Article

References (35)

1. American Psychiatric Association (1987). Diagnostic and statistical manual of mental disorders, third edition, revised. Washington, DC: American Psychiatric Association.
2. Baldessarini, R. J., & Frankenberg, F. R. (1991). Clozapine - A novel antipsychotic agent. New England Journal of Medicine, 324, 746-754.
3. Blum, A., & Girke, W. (1973). Marked increase in REM sleep produced by a new antipsychotic compound. Clinical Electroencephalography, 4, 80-84.
4. Coward, D. M., Imperato, A., Urwyler, S., & White, T. G. (1989). Biochemical and behavioural properties of clozapine. Psychopharmacology, 99, 6-12.
5. 2 antagonist, and temazepam on human sleep stages and EEG power spectra. European Journal of Pharmacology, 171, 207-218.
6. 1A agonist, on sleep patterns of healthy subjects. Psychopharmacology, 117, 186-192.
7. 2 receptors could be primarily involved in the regulation of slow-wave sleep in the rat. European Journal of Pharmacology, 137, 145-146.
8. Farde, L., & Nordström, A. L. (1992). PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients. British Journal of Psychiatry, 160 (Suppl. 17), 30-33.
9. 2-receptor occupancy in clozapine-treated patients. Journal of Clinical Psychiatry, 55 (Suppl. B), 67-69.
10. Gardner, E. L., & Seeger, T. F. (1988). Anatomically selective action of the atypical neuroleptics on the mesocorticolimbic dopamine system. Annals of the New York Academy of Sciences, 537, 502-504.
11. Gillin, J. C., Post, R. M., Wyatt, R. J., Goodwin, F. K., Snyder, F., & Bunney, W. E. (1973). REM inhibitory effect of L-dopa infusion during human sleep. Electroencephalography and Clinical Neurophysiology, 35, 181-186.
12. Gillin, J. C., van Kammen, D. P., Post, R., & Bunney, W. E. (1977). Effects of prolonged administration of pimozide on sleep-EEG patterns in psychiatric patients. Communications in Psychopharmacology, 1, 225-232.
13. Idzikowski, C., Mills, F. J., & Glennard, L. (1986). 5-Hydroxytryptamine-2 antagonist increases human slow wave sleep. Brain Research, 378, 164-168.
14. Jasper, H. H. (1958). The ten-twenty electrode system of the International Federation. Electroencephalography and Clinical Neurophysiology, 10, 371-375.
15. Kane, J., Honigfeld, G., Singer, J., & the Clozaril Collaborative Study Group (1988). Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Archives of General Psychiatry, 45, 789-796.
16. Kane, J. M., Safferman, A. Z., Pollack, S., Johns, C., Szymanski, S., Kronig, M., & Lieberman, J. A. (1994), Clozapine, negative symptoms, and extrapyramidal side effects. Journal of Clinical Psychiatry, 55 (Suppl. B), 74-77.
17. Kaplan, J., Dawson, S., Vaughan, T., Green, R., & Wyatt, R. J. (1974). Effect of prolonged chlorpromazine administration on the sleep of chronic schizophrenics. Archives of General Psychiatry, 31, 62-66.
18. Keshavan, M., Reynolds, C., Brar, J., Houck, P., Campbell, K., Ganguli, R., & McEvoy, J. (1989). Sleep EEG changes in schizophrenia during haloperidol treatment. Biological Psychiatry, 25, 181A.
19. Lauer, C. J., Riemann, D., Wiegand, M., & Berger, M. (1991). From early to late adulthood: changes in EEG sleep of depressed patients and healthy volunteers. Biological Psychiatry, 29, 979-993.
20. Lieberman, J. A., Kane, J. M., & Johns, C. A. (1989). Clozapine: guidelines for clinical management. Journal of Clinical Psychiatry, 50, 329-338.
21. McGinty, D. J., Drucker-Colin, R. R. (1982). Sleep mechanisms: biology and control of REM sleep. International Review of Neurobiology, 23, 391-436.
22. Meltzer, H. Y. (1991). Pharmacologic treatment of negative symptoms. In J. F. Greden and R. Tandon (Eds), Negative schizophrenic symptoms: Pathophysiology and clinical implications (pp. 215-231). Washington, DC: American Psychiatric Press.
23. Meltzer, H. Y. (1994). An overview of the mechanism of action of clozapine. Journal of Clinical Psychiatry, 55 (Suppl. B), 47-52.
24. Monti, J. M., Pellejero, T., Jantos, H., & Pascoe, P.A. (1985). Role of histamine in the control of sleep and waking. In A. Wauquier, J. M. Gaillard, J. M. Monti and M. Radulovack (Eds), Sleep: Neurotransmitters and neuromodulators (pp. 197-209). New York: Raven Press.
25. Nicholson, A. N., Belyavin, A. J., & Pascoe, P. A. (1989). Modulation of rapid eye movement sleep in humans by drugs that modify monoaminergic and purinergic transmission. Neuropsychopharmacology, 2, 131-143.
26. Pollmächer, T., & Schulz, H. (1993). Periodic leg movements (PLM): their relationship to sleep stages. Sleep, 16, 572-577.
27. Rechtschaffen, A., & Kales, A. (Eds) (1968). A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Bethesda, MD: National Institute of Neurological Diseases and Blindness, Neurological Information Network.
28. Richelson, E., & Nelson, A. (1984). Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro. European Journal of Pharmacology, 103, 197-204.
29. Sitaram, N., Gillin, J.C., & Bunney, W.E. (1984). Cholinergic and catecholaminergic receptor sensitivity in affective illness: strategy and theory. In R. M. Post, J. C. Ballenger (Eds), Neurobiology of mood disorders (pp. 629-651). Baltimore: Williams and Wilkins.
30. Taylor, S. F., Tandon, R., Shipley, J. E., & Eiser, A. S. (1991). Effect of neuroleptic treatment on polysomnographic measures in schizophrenia. Biological Psychiatry, 30, 904-912.
31. Touyz, S. W., Beumont, P. J. V., Saayman, G. S., & Zabow, T. (1977). A psychophysiological investigation of the short-term effects of clozapine upon sleep parameters of normal young adults. Biological Psychiatry, 12, 801-822.
32. Touyz, S. W., Saayman, G. S., & Zabow, T. (1978). A psychophysiological investigation of the long-term effects of clozapine upon sleep patterns of normal young adults. Psychopharmacology, 56, 69-73.
33. 4 receptor with high affinity for the antipsychotic clozapine. Nature, 350, 610-614.
34. Wauquier, A., van den Broeck, W. A. E., & Janssen, P. A. (1980). Biphasic effects of pimozide on sleep-wakefulness in dogs. Life Sciences, 27, 1469-1475.
35. Wittchen, H.U., Schramm, E., Zaudig, M., Spengler, P., Rummier, R., & Mombour, W. (1990). Strukturiertes Klinisches Interview für DSM-III-R. Beltz: Weinheim.